» Articles » PMID: 31481539

Differences in Genome-wide DNA Methylation Profiles in Breast Milk by Race and Lactation Duration

Abstract

Black women in the United States are disproportionately affected by early-onset, triple-negative breast cancer. DNA methylation has shown differences by race in healthy and tumor breast tissues. We examined associations between genome-wide DNA methylation levels in breast milk and breast cancer risk factors, including race, to explain how this reproductive stage influences a woman's risk for, and potentially contributes to racial disparities in, breast cancer. Breast milk samples and demographic, behavioral, and reproductive data, were obtained from cancer-free, uniparous, and lactating U.S. black ( = 57) and white ( = 82) women, ages 19-44. Genome-wide DNA methylation analysis was performed on extracted breast milk DNA using the Infinium HumanMethylation450 BeadChip. Statistically significant associations between breast cancer risk factors and DNA methylation beta values, adjusting for potential confounders, were determined using linear regression followed by Bonferroni Correction ( < 1.63 × 10). Epigenetic analysis in breast milk revealed statistically significant associations with race and lactation duration. Of the 284 CpG sites associated with race, 242 were hypermethylated in black women. All 227 CpG sites associated with lactation duration were hypomethylated in women who lactated longer. Ingenuity Pathway Analysis of differentially methylated promoter region CpGs by race and lactation duration revealed enrichment for networks implicated in carcinogenesis. Associations between DNA methylation and lactation duration may offer insight on its role in lowering breast cancer risk. Epigenetic associations with race may mediate social, behavioral, or other factors related to breast cancer and may provide insight into potential mechanisms underlying racial disparities in breast cancer incidence.

Citing Articles

A biosocial return to race? A cautionary view for the postgenomic era.

Meloni M, Moll T, Issaka A, Kuzawa C Am J Hum Biol. 2022; 34(7):e23742.

PMID: 35275433 PMC: 9286859. DOI: 10.1002/ajhb.23742.


[Peripheral blood gene methylation level is correlated with breast cancer in Chinese women].

Zhou X, Lei S, Li L, Xu T, Gu W, Ma F Nan Fang Yi Ke Da Xue Xue Bao. 2021; 41(10):1456-1463.

PMID: 34755660 PMC: 8586854. DOI: 10.12122/j.issn.1673-4254.2021.10.03.


Breast Cancer Cell Detection and Characterization from Breast Milk-Derived Cells.

Bhat-Nakshatri P, Kumar B, Simpson E, Ludwig K, Cox M, Gao H Cancer Res. 2020; 80(21):4828-4839.

PMID: 32934021 PMC: 7642166. DOI: 10.1158/0008-5472.CAN-20-1030.


Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer.

Salas L, Lundgren S, Browne E, Punska E, Anderton D, Karagas M Hum Mol Genet. 2020; 29(4):662-673.

PMID: 31943067 PMC: 7068171. DOI: 10.1093/hmg/ddz301.

References
1.
Conway K, Edmiston S, Tse C, Bryant C, Kuan P, Hair B . Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2015; 24(6):921-30. PMC: 4452445. DOI: 10.1158/1055-9965.EPI-14-1228. View

2.
Shenker N, Flower K, Wilhelm-Benartzi C, Dai W, Bell E, Gore E . Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues. BMC Cancer. 2015; 15:337. PMC: 4424887. DOI: 10.1186/s12885-015-1335-5. View

3.
Murphy J, Sherman M, Browne E, Caballero A, Punska E, Pfeiffer R . Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations. Breast Cancer Res Treat. 2016; 157(1):13-22. PMC: 5158017. DOI: 10.1007/s10549-016-3796-x. View

4.
Anderson K, Schwab R, Martinez M . Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014; 144(1):1-10. PMC: 4026199. DOI: 10.1007/s10549-014-2852-7. View

5.
Ambrosone C, Young A, Sucheston L, Wang D, Yan L, Liu S . Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget. 2013; 5(1):237-48. PMC: 3960204. DOI: 10.18632/oncotarget.1599. View